‹ All Posts
Shree Dhanraksha Securities

25th Jan · SEBI-Registered Analyst

Sector: Pharmaceuticals

Sun Pharmaceutical Industries Latest:

SUNPHARMA
received regulatory approval to sell a generic version of semaglutide (the active ingredient in Wegovy/Ozempic), entering the obesity/GLP-1 race. What it means: Generic approvals for high-demand drugs can open large new revenue streams — competition and pricing matter. Beginner tip: Evaluate launch timing, patent expiration windows, and expected pricing vs branded drugs.

#WatchOutFor#FundamentalViews#PersonalFinance#MacroViews
1,098 likes·51 comments